Literature DB >> 33768637

Docosahexaenoic and arachidonic acid supplementation at 1 year has mixed effects on development and behaviour at age 2 for preterm children.

Kelly M Boone1, Krista Pattison2, Grace Pelak3, Kelly W Sheppard1, Joseph Rausch1,4, Keith Owen Yeates5, Mary Ann Nelin6,7, Mark A Klebanoff4,8,9,10, Abigail Norris Turner8,11, Lynette K Rogers4,9, Sarah A Keim1,4,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33768637      PMCID： PMC9153214          DOI： 10.1111/apa.15858

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN： 0803-5253            Impact factor:   4.056


× No keyword cloud information.
  5 in total

1.  10-year cognition in preterms after random assignment to fatty acid supplementation in infancy.

Authors:  Elizabeth B Isaacs; Sarah Ross; Kathy Kennedy; Lawrence T Weaver; Alan Lucas; Mary S Fewtrell
Journal:  Pediatrics       Date:  2011-09-19       Impact factor: 7.124

2.  Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.

Authors:  Sarah A Keim; Kelly M Boone; Mark A Klebanoff; Abigail Norris Turner; Joseph Rausch; Mary Ann Nelin; Lynette K Rogers; Keith Owen Yeates; Leif Nelin; Kelly W Sheppard
Journal:  JAMA Pediatr       Date:  2018-12-01       Impact factor: 16.193

3.  Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial.

Authors:  Lisa G Smithers; Carmel T Collins; Lucy A Simmonds; Robert A Gibson; Andrew McPhee; Maria Makrides
Journal:  Am J Clin Nutr       Date:  2010-01-06       Impact factor: 7.045

4.  Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants.

Authors:  Mary S Fewtrell; Rebecca A Abbott; Kathy Kennedy; Atul Singhal; Ruth Morley; Eleanor Caine; Cherry Jamieson; Forrester Cockburn; Alan Lucas
Journal:  J Pediatr       Date:  2004-04       Impact factor: 4.406

5.  Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.

Authors:  Carmel T Collins; Robert A Gibson; Peter J Anderson; Andrew J McPhee; Thomas R Sullivan; Jacqueline F Gould; Philip Ryan; Lex W Doyle; Peter G Davis; Judy E McMichael; Noel P French; Paul B Colditz; Karen Simmer; Scott A Morris; Maria Makrides
Journal:  BMJ Open       Date:  2015-03-18       Impact factor: 2.692
  5 in total
  1 in total

1.  Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder.

Authors:  Sarah A Keim; Abigail Jude; Katie Smith; Aiman Q Khan; Daniel L Coury; Joseph Rausch; Shivika Udaipuria; Megan Norris; Lindsay R Bartram; Anita R Narayanan; Lynette K Rogers
Journal:  J Autism Dev Disord       Date:  2022-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.